2015 Poster Session

Freedom Ballroom, Mezzanine

Friday, April 24 | 12:00 pm – 7:00 pm
Saturday, April 25 | 7:00am – 5:30pm
Sunday, April 26 |  7:00am – 10:00am

We hope you stop by and enjoy the innovative poster submissions from across the Atlantic Derm region.  The top three posters will be presented at the Scientific Session on Sunday.

---

TOP THREE POSTERS

(in no specific order)

Prospective Clinical Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas

Daria Marley-Kemp, MD, MEd; Joya Sahu, MD; Wayne Marley, MD; Jason B. Lee, MD

Erdheim-Chester disease in a woman with history of childhood Langerhans cell histiocytosis

Julia Pettersen Neckman, MD, Joyce Kim, MD, Michael Girardi, MD

A Non-Grading Approach to Dysplastic/Clark Nevi

Daniel Lozeau, MD, Michele J. Farber, MD, Jason B. Lee, MD

---

CUTANEOUS LYMPHOMA

Folliculotropism and Syringotropism in Mycosis Fungoides: Prevalence and Clinical Impact

Claudia Hossain, B.S., Tara Jennings B.S., Wenyin Shi, M.D., S. Onder Alpdogan, M.D., Barbara Pro, M.D., Joya Sahu, M.D. 

Patient Factors Influencing Treatment with Extracorporeal Photopheresis

Crystal Agi, MD, Diane Kuhn, PhD,  Ginette Okoye, MD

CD30+ Lymphomatoid Papulosis in a Patient with Large Cell Transformation  of Mycosis Fungoides

Elizabeth Jones, M.D. and Joya Sahu, M.D.

Lower Leg Cutaneous Anaplastic Large Cell Lymphoma vs. Large Cell Transformation of Mycosis Fungoides in a patient with a history of Lymphomatoid Papulosis
 
Martina Porter M.D., Douglas Heiner M.D., Robert Fischer M.D., Marshall Kadin M.D.

Chronic Myelomonocytic Leukemia and Plasmablastic Lymphoma Presenting As Leukemia Cutis: A Case Report.  
Brandon E. Cohen, B.S., Arnaldo A. Arbini, M.D., Shane A. Meehan, M.D.,  Roger Ho, M.D., M.P.H.

Plasma cell leukemia cutis: a rare entity and grave prognosticator
Joy Wan, MD, Emily Chu, MD, PhD, Temitayo Ogunleye, MD

Remembering Richter Syndrome: Violaceous Nodules in a Patient with a History of Chronic Lymphocytic Leukemia

Lacy L. Sommer, MD and Analisa V. Halpern, MD

Rare Presentation of Aggressive CD4-CD8- Cutaneous T-Cell Lymphoma

Tara Jennings, BA,  Jamie Goldberg, MD,  Gaurav Shukla, MD,  Natalie Spaccarelli, MD,  Ellen Kim, MD, Maria Werner-Wasik, MD,  Barbara Pro, MD, Onder Alpdogan, MD, Joya Sahu, MD

Cutaneous lymphomatoid granulomatosis: A diagnostic challenge for the dermatologist

Sheila Shaigany BS, Nicole A. Weitz MD, Sameera Husain MD, Larisa Geskin MD, Marc E. Grossman MD, FACP

---

CUTANEOUS MALIGNANCY

Indeterminate Cell Sarcoma
 
Nicole Warner, MD,  Michael Ioffreda, MD

A Rapidly Growing Ulcer in an Immunosuppressed Patient

James Abbott, BS, Brett Miller, MD, Carrie Ann R. Cusack, M.D. and Mark Abdelmalek,

Targeting the TWEAK/Fn14 axis in melanoma with oligonucleotide-mediated exon skipping
Kristen M. Beck BA, Sitharam Ramaswami PhD, Wangyong Zeng PhD, Matthew S. Hayden MD PhD

---

RHEUM/DERM

Meeting the ACR and SLICC Criteria for Systemic Lupus in Patients with Subacute Cutaneous Lupus Erythematosus

Janice Tiao, BA, Victoria Werth, MD.

Classification Criteria for Amyopathic Dermatomyositis

Neelam Khan, MS, Victoria Werth, MD

Ajulemic acid, a novel cannabinoid, suppresses the secretion of key cytokines involved in the pathogenesis of dermatomyositis in vitro
Elizabeth S. Robinson, BS, Muhammad Bashir, Ph.D., Paul Alves, BA, Neelam Khan, MS, Janice Tiao, BA, Lauren Okon, M.D., Joyce Okawa, RN, MBE,  Rui Feng, Ph.D., Victoria P. Werth, M.D.

Reticular erythematous mucinosis localized to the left breast after radiation therapy for breast cancer

Joyce Kim, MD, Peggy Myung, MD, Jennifer N. Choi, MD

Atypical Behçet’s disease mimicking herpes simplex virus infection   

Daniel R. Mazori, BA, Evan Rieder, MD, Shane A. Meehan, MD, Alisa N. Femia, MD

Examining Pityriasis Rubra Pilaris from Patient and Provider Perspectives: An epidemiologic cross-sectional study of 100 PRP cases

Nicholas A. Ross, BA, Hye Jin Chung, MD, Qiaoli Li, PhD,  Jonathan Andrews, MD,  Matthew S. Keller, MD, Jouni Uitto, MD PhD  

---

PEDS DERM / GENODERMATOSES

Nipple angiofibromas with biallelic mutations in TSC2 are associated with tuberous sclerosis complex

Neera Nathan, B.A., Magdalena E. Tyburczy, Ph.D., Ji-an Wang, M.D., Mary Haughey, R.N., Amanda Jones, C.R.N.P.,  Patricia Julien-Williams, C.R.N.P.,  G. Thomas Brown, M.D., Ph.D., Chyi-Chia Richard Lee, M.D., Ph.D. , David J. Kwiatkowski, M.D., Ph.D., Joel Moss, M.D., Ph.D., and Thomas N. Darling, M.D., Ph.D

Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine

Noah A Levit, PhD, Caterina Sellitto, PhD, Hong-zhan Wang, PhD, Thomas W White, PhD

Skinning the Surface of Bone Abnormalities in Trichothiodystrophy

Allawh R., Xiong M., Tamura D., DiGiovanna J., Collins, M., Kraemer, K., Hill S.

Congenital left thigh nodule in a 1 month old girl

Diana V. Rodríguez-Rivera, BS, Kalyani S Marathe, MD, MPH

An Approach to the Neonate With Harlequin Ichthyosis

Jaimie B. Glick, MD; Kanwaljit K. Brar MD, Hieu Pham, PharmD,  Shantanu Rastogi, MD; Sharon Glick, MD

---

INFECTIOUS

Cutaneous Dissemination of Visceral Leishmaniasis Mimicking
Eruptive Lichen Planus in an AIDS Patient

Erin Wei MD, Elizabeth Yim MPH, Alan Zhou MD, Jeong-Hee Cho MD PhD,
Francisco Kerdel MD

Confirmed Lepromatous Leprosy in a Canadian non-immigrant with no history of travel to areas endemic for Leprosy

Cunningham, N. (MD​), Finlayson, L. (MD, FRCPC, FACP), Davis, I. (MD, CCFP, FRCPC​)

Disseminated Mycobacterium tuberculosis with ulceronecrotic cutaneous disease presenting as cellulitis
Kelly L. Reed, D.O., Nektarios Lountzis, M.D.

Primary Cutaneous Cryptococcus 

Amy Forrestel, MD, Badri Modi, MD, Robert Micheletti, MD

---

MEDICATION-RELATED SIDE EFFECTS & SUCCESSFUL TREATMENT

Cutaneous vasculopathy as an adverse effect of the anti-VEGF agents axitinib and cabozantinib 

Veronica J. Shi, BA, Edward W. Cowen, MD, MHSc, Rena C. Zuo, BA, Anjela Galan, MD, William Dahut, MD, Fatima Karzai, MD, Ian D. Odell, MD, PhD, Jennifer N. Choi, MD

Darkening and Eruptive Nevi During Treatment with Erlotinib

Stephen Hemperly, D.O., Tanya Ermolovich, D.O., Nektarios Lountzis, M.D., Hina Sheikh, M.D., Stephen M. Purcell, D.O.

Laboratory monitoring during isotretinoin therapy: A systematic review and meta-analysis

Young H. Lee, MD, Thomas P. Scharnitz, BS, Joshua Muscat, PhD, MPH, Gaytri Gupta-Elera, MS, Joslyn S. Kirby, MD, MS

A Case of Disseminated Granuloma Annulare Responsive to Adalimumab 
 
Marisa Wolff, D.O., Jessica Garelik D.O. , Cindy Hoffman, D.O., Damian DiCostanzo, M.D.

Repigmentation with Tofacitinib Citrate: A Pathogenesis-Based Therapy for Vitiligo 

Brittany G. Craiglow, MD, Brett A. King, MD

Pediatric livedoid vasculopathy successfully treated with rituximab

Margo H. Lederhandler, BA, Kalyani Marathe, MD, FAAD, Maria C. Garzon, MD, FAAD, FAAP, Lisa Imundo, MD,  Christine T. Lauren, MD, FAAD, FAAP

---

SURVEY & REVIEW STUDIES

Teledermatology: A review of the Ottawa experience of Otn.TeledermSF 

Ashley O’Toole MD, MHSc, Loretta Cheung MD Candidate, Steven J. Glassman MBBCh, FC Derm (SA) 

Population-Wide Wait Times For Patients Seeking Medical Vs. Cosmetic Dermatologic Care

Geeta Yadav, MD, MHS, Hanna Goldberg, BSc, Morgan Barense, PhD, Chaim Bell, MD, PhD

Sun seeking in dermatology patients contributes to disparity between sunscreen guidelines and skin cancer prevention 

Gabi Barmettler BA, Matthew Keller MD.

Perceptions of Pharmaceutical Drug Advertising in General Dermatology Patients
​
Tara Jennings, BA,  Nicholas Ross, BA,  Matthew Keller, MD

Dermoscopy: When is it useful and when is it not?

Kristen Foering, MD, Katie Osley, MD, Michael Lee, MD, Jason B. Lee, MD

---

Psoriasis Studies

IL17 and the Epidermal Differentiation Complex: Implications for psoriasis.
Mary Anderson, BSFS, Steven Daws, BA, Sitharam Ramaswami, PhD, Matthew Hayden, MD, PhD

The risk of melanoma and non-melanoma skin cancer in patients with psoriasis: a population-based cohort study in the United Kingdom.
Zelma Chiesa, MD., Daniel Shin, MS., Junko Takeshita, MD, PhD., Alexis Ogdie, MD, MSCE., Joel M. Gelfand, MD, MSCE

Effect of TNFα blockade on UV-induced changes in the skin

Jamie Langenhan BA, Elizabeth S Robinson BS, Emily Privette MD, Meena Sharma PhD, Rui Feng PhD, Jennifer Nevas CRNP, Carol Calianno CRNP, Joyce Okawa RN, Laura Taylor MD, Lisa Pappas-Taffer MD, Victoria P Werth MD

---

Educational Studies

Can We Teach Communication Skills? Patient evaluation of resident-physicians before and after evidence-based training

Nicholas A Ross, BA, Gabi Barmettler, BA,  Jason B. Lee, MD,  Matthew S. Keller, MD 

Seeing the Invisible through the Visible: Using Fine Arts in Medical Education to Improve Diagnostic Skills, Communication, and Empathy

Aneta Georgievska-Shine, Ph.D., Lynn McKinley-Grant, MD, Annette Polan, Professor Emerita

---

Abstract Submission is closed.

Poster Presentations Guidelines

Posters should be prepared in advance and brought to the meeting in person by the presenter. Do not mail your poster. Suggestions for the preparation and presentation of your poster are provided below. The first author of each poster is responsible for the proper assembly, mounting and presentation of his/her poster.

• All displays must be mounted on the assigned board by 12 pm, Friday, April 24, 2015. Posters must be removed from the display board no later than the 2 pm, Sunday, April 26, 2015. It is the responsibility of the presenter to make sure the poster is mounted and removed on time.
• Posters should be 4’x 6′ in size.
• Pushpins and board assignments will be provided at the meeting.
• Logos and advertising materials may not be used.
• When appropriate, generic names should be used instead of trademark names.
• Each poster must include a label at the top which states the title, authors, and the authors’ affiliations. Industry names may not be included in the title. The lettering of this title strip should be at least one-inch (1″) high.
• Any potential commercial conflicts of interest related to the research in the poster must be disclosed.
• Text and illustrations must be readable from a distance of at least five feet, with all lines heavily drawn. Typed materials should be on the largest typeface available

Suggested Guidelines

• The poster should be understandable without oral explanation.
• When planning your poster presentation, aim for clarity, simplicity and conciseness.
• The objective of the work should be clearly stated.
• Experimental details should be concise.
• Tables and conclusions should be clearly stated.
• When possible, organize tables and figures chronologically in vertical progression.

3 Abstract Award Winners –
Speaker Presentation Instructions

• The presentation is limited to 5 minutes, with a subsequent collective Q&A section for all three presenters.
• Presenters must use PowerPoint presentation.
• All primary and co-authors will be required to sign a Speaker CME disclosure document (will be sent at later date).
• All speaker presentations must be submitted by April 1, 2015.
• Speaker presentation is in addition to traditional poster submission (information sent in separate email).

Speaker Presentation Submission instructions:

Go to: https://www.openconf.org/ADC2015/openconf.php
Once in OpenConf, click “Make Submission.”
Then click “Speaker Presentation.”
Click Choose File and upload your presentation.
Select the appropriate “Format” in the format section.
Fill out required account information
Click “Make Submission” at bottom of page.

Questions/Correspondence

Questions related to Atlantic Derm Poster Abstracts should be sent via OpenConf link email chair. Or email: lisa.pappas-taffer@uphs.upenn.edu.

Notification of acceptance or regrets will be delivered via email to the Primary Author of each poster abstract by March 1, 2015